Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.42 USD | -2.10% | +7.17% | +225.73% |
May. 31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
Official Publications
No official publication found
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Official Publications